CMS is proposing a coverage pathway to achieve expedited and more predictable access to new medical technologies for Medicare beneficiaries.Read More »
CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.Read More »
A bipartisan group of over 30 senators recently wrote a letter to CMS to ask the agency to reevaluate the fiscal year (FY) 2024 Inpatient Prospective Payment System (IPPS) proposed rule.Read More »
Although commercial payers typically pay more per claim, it is significantly easier for providers to get reimbursed by Medicare, according to a May 2023 Crowe Revenue Cycle Analytics report.Read More »
NAHRI is hosting the sixth annual Revenue Integrity Week June 5–9. Join us in celebrating the hard work of revenue integrity professionals with team building activities, recognition programs, games, and prizes.Read More »
